Am. J. Respir. Cell Mol. Biol.,
Volume 25, Number 1, July, 2001 84-91
Cytokine-Mediated Induction of the Human Elafin Gene in Pulmonary
Epithelial Cells Is Regulated by Nuclear Factor- B
Lynne
Bingle,
Teresa D.
Tetley,
and
Colin D.
Bingle
Respiratory Cell and Molecular Biology Laboratory, Division of Genomic Medicine, University of Sheffield Medical School, Sheffield;
and Respiratory Medicine, National Heart & Lung Institute, Charing Cross Hospital, Imperial College School of Medicine, London,
United Kingdom
Elafin, a low molecular-weight proteinase inhibitor, is a member
of the recently described trappin gene family. These proteins are thought to play important roles in the regulation of inflammation and are expressed in multiple epithelia. Elafin is found
within the lung, and its expression can be induced by inflammatory mediators. The molecular mechanisms that mediate its induction are not understood. In this study we investigated the
transcriptional regulation of the elafin gene in pulmonary epithelial cell lines. Transfection of elafin promoter constructs into
the elafin-expressing pulmonary epithelial cell line A549 identified a number of positive-acting elements. Cytokine-mediated
inducibility of the elafin gene promoter was shown to occur
through a nuclear factor (NF)- B site present within the minimal
promoter. This site was shown to bind to NF- B proteins within
nuclear extracts from cytokine stimulated cell lines as well as to
in vitro-translated RelA. Cotransfection with both RelA and
NF- B-inducing kinase induced reporter gene activation via this
site, and mutagenesis experiments confirmed that it was crucial
for induction of elafin gene activity. These results clearly identify
a role for elafin in the inflammatory response of the airway epithelium to pathogenic insult and show that this response is mediated by an NF- B site within the proximal promoter.
Abbreviations: 1-proteinase inhibitor, 1-PI; activator protein, AP; base
pair(s), bp; complementary DNA, cDNA; interleukin, IL; messenger RNA,
mRNA; neutrophil elastase, NE; nuclear factor, NF; NF- B-inducing kinase, NIK; 12-O-tetradecanoylphorbol acetate, PMA; rapidly evolving
seminal vesicle-transcribed, REST; standard error of the mean, SEM;
secretory leukocyte protease inhibitor, SLPI; type II, TII; tumor necrosis
factor, TNF; whey acidic protein, WAP.
This article has been cited by other articles:

|
 |

|
 |
 
A. Bellemare, N. Vernoux, D. Morisset, and Y. Bourbonnais
Human Pre-Elafin Inhibits a Pseudomonas aeruginosa-Secreted Peptidase and Prevents Its Proliferation in Complex Media
Antimicrob. Agents Chemother.,
February 1, 2008;
52(2):
483 - 490.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. W. Butler, I. Robertson, C. M. Greene, S. J. O'Neill, C. C. Taggart, and N. G. McElvaney
Elafin Prevents Lipopolysaccharide-induced AP-1 and NF-{kappa}B Activation via an Effect on the Ubiquitin-Proteasome Pathway
J. Biol. Chem.,
November 17, 2006;
281(46):
34730 - 34735.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. E. King, H. O. D. Critchley, J.-M. Sallenave, and R. W. Kelly
Elafin in Human Endometrium: An Antiprotease and Antimicrobial Molecule Expressed during Menstruation
J. Clin. Endocrinol. Metab.,
September 1, 2003;
88(9):
4426 - 4431.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Higgins, B. R. Berridge, B. J. Mills, A. E. Schultze, H. Gao, G. H. Searfoss, T. K. Baker, and T. P. Ryan
Gene Expression Analysis of the Acute Phase Response Using a Canine Microarray
Toxicol. Sci.,
August 1, 2003;
74(2):
470 - 484.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Pilette, Y. Ouadrhiri, F. Dimanche, J.-P. Vaerman, and Y. Sibille
Secretory Component Is Cleaved by Neutrophil Serine Proteinases but its Epithelial Production Is Increased by Neutrophils through NF-{kappa}B- and p38 Mitogen-Activated Protein Kinase-Dependent Mechanisms
Am. J. Respir. Cell Mol. Biol.,
April 1, 2003;
28(4):
485 - 498.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Pol, F. Van Ruissen, and J. Schalkwijk
Development of a Keratinocyte-Based Screening Model for Antipsoriatic Drugs Using Green Fluorescent Protein Under the Control of an Endogenous Promoter
J Biomol Screen,
August 1, 2002;
7(4):
325 - 332.
[Abstract]
[PDF]
|
 |
|
Copyright © 2001 American Thoracic Society.
|
|
|